fluorouracil has been researched along with g(m1) ganglioside in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Inoue, M; Matsutani, M; Sato, S; Tsuchiya, Y; Yajima, M | 1 |
| Herberman, RB; Hiserodt, JC; Sarneva, M; Van den Brink, MR; Vujanovic, NL | 1 |
| Gazit, Z; Kedar, E | 1 |
| Arika, T; Nakahashi, S; Tsuchiya, Y; Yang, ZB | 1 |
| Goda, H; Kaji, R; Kasetani, H; Ohe, G; Okamoto, M; Sato, M; Yoshida, H | 1 |
| Chen, XF; Guo, RH; Li, J; Røe, OD; Shu, YQ; Wang, R; Wu, T; Yin, YM; Zhu, LJ | 1 |
| Ji, T; Jiao, S; Yang, J; Zhu, Y | 1 |
| Chen, G; Deng, YH; Ding, PR; Fan, WH; Feng, F; Jin, Y; Li, YH; Liang, HL; Lu, ZH; Peng, JW; Ren, C; Shi, SM; Wang, DS; Wang, F; Wang, FH; Wang, W; Wang, ZQ; Xie, CB; Xu, RH; Zhang, JW | 1 |
2 trial(s) available for fluorouracil and g(m1) ganglioside
| Article | Year |
|---|---|
Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cohort Studies; Deoxycytidine; Female; Fluorouracil; G(M1) Ganglioside; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Peripheral Nervous System Diseases; Sialic Acids; Treatment Outcome; Young Adult | 2013 |
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorouracil; G(M1) Ganglioside; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Peripheral Nervous System Diseases; Placebos; Severity of Illness Index | 2020 |
6 other study(ies) available for fluorouracil and g(m1) ganglioside
| Article | Year |
|---|---|
Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells.
Topics: Animals; Bone Marrow; Cell Division; Cells, Cultured; Fluorouracil; G(M1) Ganglioside; Glycosphingolipids; Killer Cells, Natural; Male; Mice; Mice, Inbred C3H; Sizofiran | 1991 |
Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
Topics: Animals; Antigens, Differentiation; Bone Marrow Cells; Cell Differentiation; Fluorouracil; G(M1) Ganglioside; Glycosphingolipids; Killer Cells, Natural; Leucine; Lymphocyte Activation; Lymphokines; Rats; Rats, Inbred F344 | 1989 |
Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorouracil; G(M1) Ganglioside; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude | 1994 |
Acceleration of natural killer (NK) cell recovery by a glucan, sizofiran, in anti-asialoGM1 antibody-treated mice.
Topics: Animals; Antigens, Surface; Bone Marrow Cells; Cytotoxicity Tests, Immunologic; Fluorouracil; G(M1) Ganglioside; Glucans; Interleukin-3; Interleukin-6; Killer Cells, Natural; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Rabbits; Sizofiran; Spleen; Tumor Cells, Cultured | 1993 |
cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antibodies; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Cytokines; Female; Fluorouracil; G(M1) Ganglioside; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Mice, Nude; Salivary Gland Neoplasms; Spleen; Tumor Cells, Cultured | 1998 |
The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; G(M1) Ganglioside; Humans; Leucovorin; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome | 2012 |